Table 1.
Item | Total (68) | Good prognosis (18) | Poor prognosis (50) | P-value |
---|---|---|---|---|
Male, n (%) | 49 (72.06) | 14 (77.78) | 35 (70.00) | 0.528 |
Age, years | 61.78 ± 6.65 | 61.78 ± 6.11 | 61.78 ± 6.90 | 0.741 |
Hypertension, n (%) | 45 (66.18) | 9 (50.00) | 36 (72.00) | 0.091 |
Diabetes, n (%) | 38 (55.88) | 7 (38.89) | 31 (62.00) | 0.090 |
Hyperlipidemia, n (%) | 43 (63.24) | 9 (50.00) | 34 (68.00) | 0.174 |
AF, n (%) | 15 (22.06) | 2 (11.11) | 13 (26.00) | 0.330 |
CHD, n (%) | 37 (54.41) | 8 (44.44) | 29 (58.00) | 0.322 |
Stroke, n (%) | 14 (20.59) | 4 (22.22) | 10 (20.00) | 1.000 |
Smoking, n (%) | 24 (35.29) | 6 (33.33) | 18 (36.00) | 0.839 |
Drinking, n (%) | 34 (50.00) | 10 (55.56) | 24 (48.00) | 0.582 |
Previous tumor history, n (%) | 52 (76.47) | 11 (61.11) | 41 (82.00) | 0.574 |
MT to stroke after tumor, month | 6.15 ± 3.21 | 6.86 ± 2.26 | 5.64 ± 3.02 | 0.812 |
Diagnosis after stroke, n (%) | 16 (23.53) | 7 (38.89) | 9 (18.00) | 0.871 |
MT to tumor after stroke, month | 12.39 ± 4.12 | 13.21 ± 3.22 | 10.18 ± 2.41 | 0.072 |
RBC (×1012/L) | 4.51 ± 0.75 | 4.62 ± 0.90 | 4.47 ± 0.69 | 0.833 |
WBC (×109/L) | 7.01 ± 2.10 | 7.76 ± 2.02 | 6.74 ± 2.08 | 0.810 |
PLT (×109/L) | 314.22 ± 20.85 | 306.33 ± 29.53 | 317.06 ± 16.14 | 0.326 |
Hb, g/L | 119.09 ± 10.34 | 122.56 ± 15.30 | 117.84 ± 7.69 | 0.231 |
LDL-C, mmol/L | 4.11 ± 0.72 | 3.89 ± 0.70 | 4.19 ± 0.72 | 0.130 |
Hcy, μmol/L | 18.35 ± 3.21 | 17.00 ± 3.40 | 18.84 ± 3.03a | 0.047 |
Fib, g/L | 4.30 ± 0.60 | 4.18 ± 0.57 | 4.34 ± 0.61 | 0.981 |
D-dimer, mg/L | 1.89 ± 0.85 | 1.24 ± 0.70 | 2.12 ± 0.78a | <0.001 |
TAT, ng/ml | 6.93 ± 3.98 | 3.75 ± 1.40 | 8.07 ± 3.99a | <0.001 |
One territory sign | 7 (10.29) | 4 (22.22) | 3 (6.00) | 0.136 |
Two territory sign | 25 (36.76) | 4 (22.22) | 21 (42.00) | 0.136 |
Three territory sign | 30 (44.12) | 4 (22.22) | 26 (52.00)a | 0.029 |
Cardiac valvular vegetations | 13 (19.12) | 2 (11.11) | 11 (22.00) | 0.511 |
CHD, coronary heart disease; AF, atrial fibrillation; MT, mean time; RBC, Red blood cell; WBC, White blood cell; PLT, Platelet; Hb, Hemoglobin; LDL-C, low-density lipoprotein cholesterol; Hcy, homocysteine; Fib, fibrinogen; TAT, thrombin-antithrombin complex.
P < 0.05, as compared to poor prognosis.